| Ms Katelyn Mary Lucy, CNM | |
|
21 Belmont Ave, Brattleboro, VT 05301-7110 | |
| (802) 251-9965 | |
| (802) 251-9972 |
| Full Name | Ms Katelyn Mary Lucy |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 8 Years |
| Location | 21 Belmont Ave, Brattleboro, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427590405 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | (* (Not Available)) | Secondary |
| 363LX0001X | Nurse Practitioner - Obstetrics & Gynecology | 101.0125383 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Brattleboro Memorial Hospital | Brattleboro, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brattleboro Memorial Hospital | 9335112929 | 74 |
News Archive
"Dilma Rousseff had barely been confirmed as Brazil's new president in November when she made her first foreign visit, to Mozambique," which "included a symbolic stop-off at a pharmaceutical factory that is under construction in preparation for opening in 2014. … The plant will produce a range of medicines for one of its leading lusophone - Portuguese-speaking - African partners, marking the resurgent power and growing reach of its sponsor, Brazil's own state-led drug sector," the Financial Times writes in an article that examines the partnerships Brazil is establishing at home and abroad.
CEL-SCI Corporation announced today it has received approval from seven hospital Institutional Review Boards in India to begin enrollment of subjects for a Phase III clinical trial of Multikine, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer.
Inhibitex, Inc., announced today that it has successfully completed a Phase1a, first-in-man, single ascending dose trial of INX-189, its nucleotide polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV) infections. In this trial, 42 healthy volunteers received either a single oral dose of INX-189, ranging from 3 mg to 100 mg, or placebo. The Company plans to present detailed results from this trial during a future scientific meeting.
Men who start to lose hair at the age of 20 are more likely to develop prostate cancer in later life and might benefit from screening for the disease, according to a new study published online in the cancer journal, Annals of Oncology today.
"A global study mapping human diseases that come from animals like tuberculosis, AIDS, bird flu or Rift Valley fever has found that just 13 such diseases are responsible for 2.4 billion cases of human illness and 2.2 million deaths a year," Reuters reports.
› Verified 5 days ago
| Entity Name | Brattleboro Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306849708 PECOS PAC ID: 9335112929 Enrollment ID: O20040929000782 |
News Archive
"Dilma Rousseff had barely been confirmed as Brazil's new president in November when she made her first foreign visit, to Mozambique," which "included a symbolic stop-off at a pharmaceutical factory that is under construction in preparation for opening in 2014. … The plant will produce a range of medicines for one of its leading lusophone - Portuguese-speaking - African partners, marking the resurgent power and growing reach of its sponsor, Brazil's own state-led drug sector," the Financial Times writes in an article that examines the partnerships Brazil is establishing at home and abroad.
CEL-SCI Corporation announced today it has received approval from seven hospital Institutional Review Boards in India to begin enrollment of subjects for a Phase III clinical trial of Multikine, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer.
Inhibitex, Inc., announced today that it has successfully completed a Phase1a, first-in-man, single ascending dose trial of INX-189, its nucleotide polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV) infections. In this trial, 42 healthy volunteers received either a single oral dose of INX-189, ranging from 3 mg to 100 mg, or placebo. The Company plans to present detailed results from this trial during a future scientific meeting.
Men who start to lose hair at the age of 20 are more likely to develop prostate cancer in later life and might benefit from screening for the disease, according to a new study published online in the cancer journal, Annals of Oncology today.
"A global study mapping human diseases that come from animals like tuberculosis, AIDS, bird flu or Rift Valley fever has found that just 13 such diseases are responsible for 2.4 billion cases of human illness and 2.2 million deaths a year," Reuters reports.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Katelyn Mary Lucy, CNM 115 Frost St, Brattleboro, VT 05301-6530 Ph: (802) 681-8303 | Ms Katelyn Mary Lucy, CNM 21 Belmont Ave, Brattleboro, VT 05301-7110 Ph: (802) 251-9965 |
News Archive
"Dilma Rousseff had barely been confirmed as Brazil's new president in November when she made her first foreign visit, to Mozambique," which "included a symbolic stop-off at a pharmaceutical factory that is under construction in preparation for opening in 2014. … The plant will produce a range of medicines for one of its leading lusophone - Portuguese-speaking - African partners, marking the resurgent power and growing reach of its sponsor, Brazil's own state-led drug sector," the Financial Times writes in an article that examines the partnerships Brazil is establishing at home and abroad.
CEL-SCI Corporation announced today it has received approval from seven hospital Institutional Review Boards in India to begin enrollment of subjects for a Phase III clinical trial of Multikine, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer.
Inhibitex, Inc., announced today that it has successfully completed a Phase1a, first-in-man, single ascending dose trial of INX-189, its nucleotide polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV) infections. In this trial, 42 healthy volunteers received either a single oral dose of INX-189, ranging from 3 mg to 100 mg, or placebo. The Company plans to present detailed results from this trial during a future scientific meeting.
Men who start to lose hair at the age of 20 are more likely to develop prostate cancer in later life and might benefit from screening for the disease, according to a new study published online in the cancer journal, Annals of Oncology today.
"A global study mapping human diseases that come from animals like tuberculosis, AIDS, bird flu or Rift Valley fever has found that just 13 such diseases are responsible for 2.4 billion cases of human illness and 2.2 million deaths a year," Reuters reports.
› Verified 5 days ago
Ms. Emily C Martyn, CNM Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 21 Belmont Ave, Brattleboro Ob-gyn, 1st Floor, Brattleboro, VT 05301 Phone: 802-251-9965 | |
Julia Mcdougal Ronconi, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 130 Austine Dr, Brattleboro, VT 05301 Phone: 802-380-1971 Fax: 802-419-3844 | |
Agnes Mikijaniec, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 17 Belmont Ave, Att'n: Marilyn Boudreau, Brattleboro, VT 05301 Phone: 802-257-8382 Fax: 802-251-8466 | |
Heather L Baribault, PNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 21 Belmont Ave, Brattleboro, VT 05301 Phone: 802-258-3905 Fax: 802-258-4903 | |
Katherine Jane Baker, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 57 Western Ave, Brattleboro, VT 05301 Phone: 802-254-0252 Fax: 802-254-0253 | |
Deborah L Jones, RN FNP AACRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 17 Belmont Ave, Att'n: Marilyn Boudreau, Brattleboro, VT 05301 Phone: 802-257-8382 Fax: 802-251-8466 | |
Karen Behringer, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 402 Canal St, Brattleboro, VT 05301 Phone: 802-257-0534 |